Department of Medicine

A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy.

November is well-known as Lung Cancer Awareness Month. It is also the month that highlights awareness of less publicized forms of cancer including pancreatic cancer and stomach cancer.

Can an implanted electrical device like a cardiac pacemaker effectively treat inflammatory diseases like rheumatoid arthritis, including cases that have not responded to drug therapy?

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.

Nancy J. Cox, Ph.D., professor of Medicine and Human Genetics and chief of the Section of Genetic Medicine at the University of Chicago, has been appointed founding director of a new genetics institute at Vanderbilt University, effective Jan. 1, 2015.

A nationwide research group headed by Vanderbilt University’s David Robertson, M.D., has received another round of funding from the federal government to continue studies of rare neurodegenerative diseases and disorders affecting blood pressure.

Vanderbilt University is part of a national effort to improve diabetes treatment by developing strategies for proliferating, regenerating and improving the function of insulin-producing beta cells in the pancreatic islets.